The 2019 American Cancer Society report on breast cancer statistics highlights key trends in incidence, mortality, and survival in the United States. Breast cancer incidence rates increased slightly by 0.3% per year from 2012-2016, driven by rising local-stage and hormone receptor-positive cases. However, breast cancer mortality rates have declined significantly, dropping 40% from 1989 to 2017, with a 1.3% annual decrease from 2011-2017. Despite this decline, the black-white mortality disparity remains stable, with black women having a 40% higher death rate than white women, largely due to differences in tumor characteristics, access to care, and other factors. Breast cancer is the leading cause of cancer death among black women in four Southern and two Midwestern states, and among white women in Utah. The report also notes that breast cancer mortality rates have slowed in some states, including Nebraska, Colorado, and Wisconsin for black women, and Nebraska, Texas, and Virginia for white women. Incidence rates vary by race and ethnicity, with white women having the highest rates, followed by black women, and Asian/Pacific Islanders having the lowest. However, black women have the highest mortality rates, with a 40% higher rate than white women. The incidence of HR-positive/HER2-negative breast cancer is highest in white women, while triple-negative breast cancer is more common in black women. Survival rates vary by stage and race, with black women having lower survival rates, particularly for stage III breast cancer. Treatment patterns show that breast-conserving surgery is increasingly used, but mastectomy is also common, especially among younger patients. Chemotherapy use has increased, particularly for HER2-positive and triple-negative breast cancers. The report emphasizes the need for improved access to prevention, early detection, and treatment services to further reduce breast cancer mortality. It also highlights the importance of addressing health disparities, particularly among black women, through targeted interventions and improved healthcare access.The 2019 American Cancer Society report on breast cancer statistics highlights key trends in incidence, mortality, and survival in the United States. Breast cancer incidence rates increased slightly by 0.3% per year from 2012-2016, driven by rising local-stage and hormone receptor-positive cases. However, breast cancer mortality rates have declined significantly, dropping 40% from 1989 to 2017, with a 1.3% annual decrease from 2011-2017. Despite this decline, the black-white mortality disparity remains stable, with black women having a 40% higher death rate than white women, largely due to differences in tumor characteristics, access to care, and other factors. Breast cancer is the leading cause of cancer death among black women in four Southern and two Midwestern states, and among white women in Utah. The report also notes that breast cancer mortality rates have slowed in some states, including Nebraska, Colorado, and Wisconsin for black women, and Nebraska, Texas, and Virginia for white women. Incidence rates vary by race and ethnicity, with white women having the highest rates, followed by black women, and Asian/Pacific Islanders having the lowest. However, black women have the highest mortality rates, with a 40% higher rate than white women. The incidence of HR-positive/HER2-negative breast cancer is highest in white women, while triple-negative breast cancer is more common in black women. Survival rates vary by stage and race, with black women having lower survival rates, particularly for stage III breast cancer. Treatment patterns show that breast-conserving surgery is increasingly used, but mastectomy is also common, especially among younger patients. Chemotherapy use has increased, particularly for HER2-positive and triple-negative breast cancers. The report emphasizes the need for improved access to prevention, early detection, and treatment services to further reduce breast cancer mortality. It also highlights the importance of addressing health disparities, particularly among black women, through targeted interventions and improved healthcare access.